INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 192 filers reported holding INSMED INC in Q3 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,387,004 | +20.8% | 1,876,713 | +0.9% | 0.02% | +33.3% |
| Q2 2023 | $39,229,205 | +14.8% | 1,859,204 | -7.3% | 0.01% | +9.1% |
| Q1 2023 | $34,183,836 | -43.0% | 2,004,917 | -33.2% | 0.01% | -47.6% |
| Q4 2022 | $59,948,000 | -4.2% | 3,000,301 | +3.2% | 0.02% | -8.7% |
| Q3 2022 | $62,600,000 | +17.2% | 2,906,206 | +7.3% | 0.02% | +21.1% |
| Q2 2022 | $53,426,000 | -34.8% | 2,709,180 | -22.2% | 0.02% | -20.8% |
| Q1 2022 | $81,880,000 | -27.7% | 3,484,229 | -16.2% | 0.02% | -22.6% |
| Q4 2021 | $113,276,000 | -1.4% | 4,158,422 | -0.3% | 0.03% | -16.2% |
| Q3 2021 | $114,832,000 | -0.7% | 4,169,652 | +2.6% | 0.04% | +2.8% |
| Q2 2021 | $115,688,000 | +0.4% | 4,064,771 | +20.2% | 0.04% | -5.3% |
| Q1 2021 | $115,185,000 | +17.6% | 3,381,817 | +15.0% | 0.04% | +8.6% |
| Q4 2020 | $97,927,000 | +29.2% | 2,941,597 | +24.8% | 0.04% | +12.9% |
| Q3 2020 | $75,773,000 | +8.7% | 2,357,602 | -6.8% | 0.03% | +3.3% |
| Q2 2020 | $69,688,000 | +113.0% | 2,530,610 | +24.0% | 0.03% | +76.5% |
| Q1 2020 | $32,716,000 | -40.1% | 2,040,997 | -10.7% | 0.02% | -26.1% |
| Q4 2019 | $54,601,000 | +64.2% | 2,286,384 | +21.3% | 0.02% | +53.3% |
| Q3 2019 | $33,246,000 | +353.1% | 1,884,688 | +557.7% | 0.02% | +400.0% |
| Q2 2019 | $7,337,000 | +0.5% | 286,571 | +14.1% | 0.00% | 0.0% |
| Q1 2019 | $7,299,000 | +37.8% | 251,142 | -37.8% | 0.00% | 0.0% |
| Q4 2018 | $5,296,000 | -29.5% | 403,629 | +8.6% | 0.00% | 0.0% |
| Q3 2018 | $7,516,000 | -13.3% | 371,746 | +1.4% | 0.00% | -25.0% |
| Q2 2018 | $8,671,000 | +19.3% | 366,630 | +13.7% | 0.00% | +33.3% |
| Q1 2018 | $7,266,000 | -18.5% | 322,588 | +12.9% | 0.00% | -25.0% |
| Q4 2017 | $8,910,000 | -4.4% | 285,746 | -4.3% | 0.00% | 0.0% |
| Q3 2017 | $9,316,000 | +642.3% | 298,513 | +308.3% | 0.00% | +300.0% |
| Q2 2017 | $1,255,000 | -19.5% | 73,119 | -17.9% | 0.00% | 0.0% |
| Q1 2017 | $1,559,000 | +18.6% | 89,072 | -10.4% | 0.00% | 0.0% |
| Q4 2016 | $1,314,000 | -7.3% | 99,386 | +1.9% | 0.00% | 0.0% |
| Q3 2016 | $1,418,000 | -52.7% | 97,568 | -67.9% | 0.00% | -50.0% |
| Q2 2016 | $2,998,000 | +3.1% | 303,803 | +32.3% | 0.00% | 0.0% |
| Q1 2016 | $2,908,000 | -17.2% | 229,579 | +18.6% | 0.00% | 0.0% |
| Q4 2015 | $3,513,000 | -8.0% | 193,637 | -5.9% | 0.00% | 0.0% |
| Q3 2015 | $3,819,000 | -19.2% | 205,709 | +6.3% | 0.00% | -33.3% |
| Q2 2015 | $4,728,000 | +67.0% | 193,598 | +42.3% | 0.00% | +50.0% |
| Q1 2015 | $2,831,000 | +52.6% | 136,088 | +13.5% | 0.00% | +100.0% |
| Q4 2014 | $1,855,000 | -81.1% | 119,917 | -84.1% | 0.00% | -83.3% |
| Q3 2014 | $9,830,000 | -30.3% | 753,315 | +6.7% | 0.01% | -25.0% |
| Q2 2014 | $14,106,000 | -20.7% | 706,003 | -24.4% | 0.01% | -27.3% |
| Q1 2014 | $17,781,000 | +34.0% | 934,020 | +19.8% | 0.01% | +37.5% |
| Q4 2013 | $13,267,000 | +2.5% | 779,879 | -6.0% | 0.01% | 0.0% |
| Q3 2013 | $12,945,000 | +1398.3% | 829,250 | +1048.6% | 0.01% | +700.0% |
| Q2 2013 | $864,000 | – | 72,194 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |